Market Cap
₹9,250 Cr.
P/E
74.14
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
14.46%
3yr Average
21.51%
5yr Average
23.51%
Net Profit Margin
Latest
12.44%
3yr Average
16.08%
5yr Average
15.78%
ROCE
Latest
15.59%
3yr Average
22.91%
5yr Average
26.32%
Debt to Equity
Latest
0.08
3yr Average
0.12
5yr Average
0.08
Revenue mix

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Customer Segment

locked
Source
|
Latest
|
locked
Historic

Distribution Channel

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic

Test Mix

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Number of Diagnostic Centres (.)
    • Realization/Patient - Diagnostic Centres (Rs/Patient)
    • Number of Daily Patients - Diagnostic Centres (Ths)
    • Realization/Test - Diagnostic Centres (Rs/Test)
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis